netFormulary NHS
Shropshire and Telford Local Health Economy
Shropshire, Telford and Wrekin CCG
Shrewsbury and Telford Hospitals NHS Trust
Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
Shropshire Community Health NHS Trust
 Search
 Formulary Chapter 2: Cardiovascular system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
02.01.01 Cardiac glycosides (1,0)
Digoxin-specific antibody (1,0)
02.01.02 Phosphodiesterase type-3 inhibitors (1,0)
02.02.01 Thiazides and related diuretics (3,0)
02.02.02 Loop diuretics (2,0)
02.02.03 Potassium-sparing diuretics and aldosterone antagonists (1,0)
Aldosterone antagonists (2,0)
02.02.04 Potassium-sparing diuretics with other diuretics (1,0)
02.02.05 Osmotic diuretics (1,0)
02.03.02 Drugs for arrhythmias (0,0)
Supraventricular arrhythmias (2,0)
Supraventricular and ventricular arrhythmias (5,0)
02.04 Beta-adrenoceptor blocking drugs (8,0)
02.05.01 Vasodilator antihypertensive drugs (9,1)
02.05.02 Centrally acting antihypertensive drugs (3,0)
02.05.04 Alpha-adrenoceptor blocking drugs (2,1)
Phaeochromocytoma (1,0)
02.05.05.01 Angiotensin-converting enzyme inhibitors (ACE inhibitors) (5,1)
02.05.05.02 Angiotensin-II receptor antagonists (5,0)
02.05.05.03 Renin inhibitors (0,1)
02.06.01 Nitrates (4,0)
02.06.02 Calcium-channel blockers (13,0)
02.06.03 Other anitanginal drugs (3,0)
02.06.04 Peripheral vasodilators and related drugs (4,0)
02.07.01 Inotropic sympathomimetics (3,0)
02.07.02 Vasoconstrictor sympathomimetics (5,0)
02.07.03 Cardiopulmonary resuscitation (1,0)
02.08.01 Parenteral anticoagulants (1,0)
Heparin (1,0)
Low molecular weight heparins (2,0)
Heparin flushes (1,0)
Epoprostenol (1,0)
Fondaparinux (1,0)
02.08.02 Oral anticoagulants (8,0)
02.08.03 Protamine sulphate (1,0)
02.09 Antiplatelet drugs (7,0)
02.10.02 Fibrinolytic drugs (3,0)
02.11 Antifibrinolytic drugs and haemostatics (1,0)
Blood-related products (4,1)
02.12 Lipid-regulating drugs (4,1)
Bile acid sequestrants (2,0)
Ezetimibe (1,0)
Fibrates (2,0)
Statins (4,0)
Nicotinic acid group (1,0)
Omega-3 fatty acid compounds (0,1)
netFormulary